Search Results 1521-1530 of 20017 for Hepatitis b

1. A Study to Evaluate Daratumumab in Treating Transplant-Eligible Participants with Multiple Myeloma - Mayo Clinic

   Known Hepatitis B or Hepatitis C infection. Exhibiting clinical signs of meningeal involvement of multiple myeloma. Known severe chronic obstructive ...

2. JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations - Mayo Clinic

   Active infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) requiring treatment within the last week prior to ...

3. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   ... B-cell lymphoma with intermediate features between DLBCL and Burkitt's ... hepatitis B. Known Human Immunodeficiency Virus (HIV) infection. Second ...

4. A Study of LY3154207 in Participants With Parkinson's Disease Dementia or Dementia with Lewy Bodies - Mayo Clinic

   Participants with acute liver disease (e.g., acute viral hepatitis, alcoholic hepatitis); participants with a known chronic liver disease (e.g., hepatitis B ...

5. A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT) - Mayo Clinic

   Hepatitis C virus detectable by polymerase chain reaction at screening or documented in pre-HSCT medical record. Chronic inactive hepatitis B virus with ...

6. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Known or active bacterial, viral, and fungal infection including tuberculosis, active Hepatitis B (e.g., HBsAg reactive), or Hepatitis C (e.g., RNA [qualitative] ...

7. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

   For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.

8. Measles and rubella virus vaccine live (intramuscular route, injection route) - Side effects & dosage - Mayo Clinic

   Hepatitis B Immune Globulin; Rabies Immune Globulin; Respiratory Syncytial Virus Immune Globulin, Human; Tetanus Immune Globulin; Vaccinia Immune Globulin ...

9. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   hepatitis B virus (HBV) or hepatitis C virus (HCV) infection at screening (positive HBV surface antigen or HCV RNA if anti-HCV antibody screening test is ...

10. Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma - Mayo Clinic

    Known hepatitis B or hepatitis C infection. Other active malignancy. Females only: Pregnant or breastfeeding. Prior stem cell transplantation. Acute ...